References: Volatile inhalants: hazardous, harmful and dependent use

Alcohol and Drug Foundation (ADF). Amyl nitrite. ADF. 2021; Accessed September 2022. https://adf.org.au/drug-facts/amyl-nitrite/
Australian Institute of Health and Welfare (AIHW). National Drug Strategy Household Survey 2019. Canberra: Australian Government, AIHW; 2020. https://www.aihw.gov.au/about-our-data/our-data-collections/national-drug-strategy-household-survey/2019-ndshs
Francis C. Cameron Francis - Responding to inhalant use in Queensland. Insight, editor. Insight Seminar Series: Insight Queensland; 2020. https://insight.qld.edu.au/training/responding-to-inhalant-use-in-queensland/detail
Nguyen J, O'Brien C, Schapp S. Adolescent inhalant use prevention, assessment, and treatment: A literature synthesis. Int J Drug Policy 2016;31:15-24. https://www.ncbi.nlm.nih.gov/pubmed/26969125
Perron BE, Howard MO, Vaughn MG, Jarman CN. Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder. Med Hypotheses 2009;73(6):935-7. https://www.ncbi.nlm.nih.gov/pubmed/19632058
Shen Y, Chen S. Clinical Aspects of Inhalant Addiction. In: Johnson BA. Addiction Medicine: Science and Practice. 2^nd ed. Elsevier; 2020.
The Royal Children's Hospital Melbourne (RCH). Clinical Practice Guidelines: Inhalants Volatile Substance Use - Chroming. RCH; Updated October 2020. Accessed September 2022. https://www.rch.org.au/clinicalguide/guideline_index/inhalants_volatile_substance_use/